TMCnet News
Investors look to Lighten Up on Shares of BioCryst Pharmaceuticals, Shares Down 9.9% (BCRX)Dec 03, 2012 (SmarTrend(R) Spotlight via COMTEX) -- BioCryst Pharmaceuticals (NASDAQ:BCRX) is one of today's worst performing low-priced stocks, down 9.9% to $1.55 on 1.2x average daily volume. Thus far today, BioCryst Pharmaceuticals has traded 789,000 shares, vs. average volume of 676,000 shares per day. The stock has underperformed the Dow (-9.9% to the Dow's 0.0%) and underperformed the S&P 500 (-9.9% to the S&P's 0.0%) during today's trading. BioCryst Pharmaceuticals, Inc., a biopharmaceutical company, discovers and designs novel small-molecule pharmaceuticals using structure-based drug design. The Company's products are used for the treatment of immunological, viral, and cardiovascular diseases and disorders. BioCryst's lead immunological drug program targets T-cell proliferative disorders. BioCryst Pharmaceuticals share prices have moved between a 52-week high of $5.95 and a 52-week low of $1.08 and are now trading 44% above that low price at $1.55 per share. In the last five trading sessions, the 50-day moving average (MA) has fallen 2.1% while the 200-day MA has remained constant. Potential upside of 115.0% exists for BioCryst Pharmaceuticals, based on a current level of $1.55 and analysts' average consensus price target of $3.33. The stock should run into initial resistance at its 200-day moving average (MA) of $4.08 and subsequent resistance at its 50-day MA of $4.09. SmarTrend is monitoring the recent change of momentum in BioCryst Pharmaceuticals. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of BioCryst Pharmaceuticals in search of a potential trend change. Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup |